John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$175M |
| 2 |
Meta Platforms (Facebook)
META
|
+$163M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$138M |
| 4 |
Constellation Brands
STZ
|
+$135M |
| 5 |
Johnson & Johnson
JNJ
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$173M |
| 2 |
Pfizer
PFE
|
+$159M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$136M |
| 4 |
Dominion Energy
D
|
+$133M |
| 5 |
eBay
EBAY
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.76% |
| 2 | Consumer Discretionary | 11% |
| 3 | Industrials | 10.42% |
| 4 | Healthcare | 9.63% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Genuine Parts
GPC
$18.5B
| $24.3M | 0.07% |
264,728
-31,786
| -11% | -$2.9M |
|
352
Ameren
AEE
$29.4B
| $24.2M | 0.07% |
+397,369
| New | +$22.8M |
|
353
PepsiCo
PEP
$196B
| $24.1M | 0.07% |
221,540
-1,017,805
| -82% | -$105M |
|
354
Lazard
LAZ
$4.3B
| $24.1M | 0.07% |
492,913
+286,165
| +138% | +$15.1M |
|
355
CALL
Berkshire Hathaway Class B
BRK.B
$1.06T
| $24.1M | 0.07% |
129,100
+125,100
| +3,128% | +$24.4M |
|
356
Yum China
YUMC
$16.9B
| $24M | 0.07% |
623,964
-220,489
| -26% | -$8.73M |
|
357
Annaly Capital Management
NLY
$17.5B
| $24M | 0.07% |
582,629
+500,983
| +614% | +$20.9M |
|
|
358
PUT
PepsiCo
PEP
$196B
| $23.9M | 0.07% |
219,700
+186,300
| +558% | +$19.2M |
|
359
First Hawaiian
FHB
$3.2B
| $23.9M | 0.07% |
822,352
+640,476
| +352% | +$18.5M |
|
|
ALXN
360
DELISTED
Alexion Pharmaceuticals
ALXN
| $23.8M | 0.07% |
+191,398
| New | +$22.4M |
|
|
DOCU
361
DocuSign
DOCU
$11.8B
| $23.7M | 0.07% |
+448,171
| New | +$22.6M |
|
|
CELG
362
CALL
DELISTED
Celgene Corp
CELG
| $23.7M | 0.07% |
298,600
+227,600
| +321% | +$18.9M |
|
363
Nektar Therapeutics
NKTR
$2.53B
| $23.6M | 0.07% |
+32,160
| New | +$37.1M |
|
|
CGC
364
Canopy Growth
CGC
$472M
| $23.4M | 0.07% |
+80,172
| New | +$24.3M |
|
365
CALL
Coca-Cola
KO
$392B
| $23.3M | 0.07% |
531,500
+77,400
| +17% | +$3.34M |
|
366
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$46.4B
| $23.2M | 0.07% |
95,400
-261,700
| -73% | -$64.2M |
|
367
Nasdaq
NDAQ
$54.9B
| $23.1M | 0.07% |
759,972
-408,042
| -35% | -$12.3M |
|
368
Insulet
PODD
$10.3B
| $23.1M | 0.07% |
269,676
+138,358
| +105% | +$12.4M |
|
|
XLNX
369
DELISTED
Xilinx Inc
XLNX
| $23M | 0.07% |
351,913
+313,924
| +826% | +$21.4M |
|
370
Sabre
SABR
$848M
| $22.8M | 0.07% |
923,540
+3,197
| +0.3% | +$74.1K |
|
371
Walmart Inc
WMT
$825B
| $22.7M | 0.07% |
+795,939
| New | +$22.6M |
|
|
372
PUT
Berkshire Hathaway Class B
BRK.B
$1.06T
| $22.7M | 0.07% |
121,500
+116,500
| +2,330% | +$22.7M |
|
373
Blackrock
BLK
$179B
| $22.4M | 0.07% |
44,924
+42,225
| +1,564% | +$22.3M |
|
|
374
PUT
Booking.com
BKNG
$158B
| $22.3M | 0.07% |
275,000
+132,500
| +93% | +$11.2M |
|
|
INFO
375
DELISTED
IHS Markit Ltd. Common Shares
INFO
| $22.3M | 0.07% |
431,662
+407,872
| +1,714% | +$20.4M |
|
Similar funds
John Overdeck's Q2 2018 Portfolio in Review
As of Q2 2018, John Overdeck held 3,907 positions worth $33.5B, up 12% from $30B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
John Overdeck deployed $2.27B of net new capital in Q2 2018, opening 829 new positions and adding to 1,295 existing holdings. Its largest new stake was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $173M trimmed.
- John Overdeck's largest Q2 2018 buy was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
- John Overdeck added most to Abiomed Inc in Q2 2018, an estimated $138M increase.
- John Overdeck's biggest Q2 2018 reduction was Booking.com, cutting an estimated $173M.
- John Overdeck fully exited Pfizer in Q2 2018, selling an estimated $159M.
- John Overdeck's ten largest holdings make up 5.6% of its $33.5B portfolio in Q2 2018.
- John Overdeck opened 829 new positions and closed 662 in Q2 2018.
- John Overdeck's portfolio value rose 12% quarter-over-quarter to $33.5B.
Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.